Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)
1 clinical trials · Condition
◉ Watch Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors (NCT03114319) | Novartis Pharmaceuticals | 2017-05-26 |
Track Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.